Phase II trial of oral vorinostat (SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
Year: 2007
Type: article
Source: Blood
Author: Duvic
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3169660104
